Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$550 Buy
53
+52
+5,200% +$547 ﹤0.01% 4667
2026
Q1
$9 Sell
1
-1
-50% -$12 ﹤0.01% 4975
2025
Q4
$25 Buy
+2
New +$27 ﹤0.01% 4787

Other funds holding CARL

IFP Advisors's CARL Position: Q2 2026 in Review

IFP Advisors increased its Carlsmed (CARL) stake by 5,200% in Q2 2026, buying an estimated $547 and bringing the position to 53 shares worth $550. The position accounts for ﹤0.01% of the portfolio, ranked #4667.

IFP Advisors first reported a position in CARL in Q4 2025 and has held it in 3 quarters since. 14 funds tracked by Wall St. Rank hold CARL as of Q2 2026.

  • IFP Advisors held 53 shares of Carlsmed worth $550 as of Q2 2026.
  • IFP Advisors bought 52 Carlsmed shares in Q2 2026, an estimated $547.
  • Carlsmed made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4667 holding.
  • IFP Advisors first reported a position in Carlsmed in Q4 2025 and has held it in 3 quarters since.
  • 14 funds tracked by Wall St. Rank held Carlsmed as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.